Actinogen Medical LimitedASX: ACW

Notification of cessation of securities - ACW

Sep 15, 2026 at 10:43 PM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Sep 15, 2026 at 10:43 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-acw

Release

Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 4Announcement SummaryEntity nameACTINOGEN MEDICAL LIMITEDAnnouncement TypeNew announcementDate of this announcementWednesday September 16, 2026Details of +securities that have ceasedASX...

Actinogen Medical Limited on 6ix

Earlier from Actinogen Medical

Application for quotation of securities - ACWSep 15
Appendix 3Y-Dr Geoffrey BrookeSep 8
ACW CMO international Xanamem presentationSep 8
Response to ASX Price QuerySep 4
ACW unlisted options fully underwrittenAug 31

Later from Actinogen Medical

ACW Alzheimers pivotal trial completes last patient visitSep 22
Options underwriting cleansing noticeSep 22
Underwriting of unlisted options completedSep 22
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberSep 23
AGM date and closing date for director nominationsOct 8

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical